Pfizer s all-electronic

Pfizer clinical trial results

Pfizer registers (1) all Pfizer-sponsored interventional studies in human subjects that evaluate the safety and/or efficacy of a Pfizer product (ie, drug, biologic or device); and (2) all Pfizer-sponsored non-interventional studies, regardless of design or data source, where the primary endpoint is to study whether a Pfizer product is associated with an increased incidence of a specific safety outcome. We register all of these studies on www.clinicaltrials.gov.

Posting Study Results

Pfizer submits study results in a tabular format mandated by the United States National Institutes of Health for posting on We submit results for all of the Pfizer sponsored studies that have been registered on not including phase I studies in healthy volunteers.

Pfizer submits study results as follows:

Pre-approval studies: For Pfizer-sponsored studies completed prior to submission of the initial marketing authorization application, Pfizer submits the study results for posting within one year of the first approval/clearance outside of the US for products that will only be marketed outside of the US. For studies subject to the FDA Amendments Act Title VIIII, Pfizer posts results on within 30 calendar days of the FDA marketing authorization.

  • Post-approval studies: For Pfizer-sponsored studies involving products already approved for sale in any country, Pfizer submits the study results for posting within one year of the date of the last subject's last visit date. For studies subject to the FDA Amendments Act of 2008 Title VIII, Pfizer posts results of those studies within one year of the pre-defined primary completion date for the study.
  • Discontinued Programs: For Pfizer-sponsored studies involving an unapproved product for which development of the compound has been discontinued, Pfizer submits the study results for posting within two years (of the date of discontinuation of development of the compound).

In all cases, study results are reported by Pfizer in an objective, accurate, balanced, and complete manner - regardless of the outcome of the study or the country(ies) in which the study was conducted.

You might also like
DS Healthcare (DSKX) Announces Results from New Clinical Study
DS Healthcare (DSKX) Announces Results from New Clinical Study
See The Clinical Trial Results Of The Beachbody Ultimate Reset
See The Clinical Trial Results Of The Beachbody Ultimate Reset
PFIZER CONSUMER. Mens Rogaine Extra Strength 5% Minoxidil Topical Foam - 2.11 Oz
Beauty (PFIZER CONSUMER.)
  • The only topical brand FDA-approved to regrow hair-in both men and women
  • Dermatologist-recommended brand for hair regrowth
  • Helps reverse the progression of hereditary hair loss
  • Regrew hair in 85% of men after 4 months when used twice daily in clinical testing

BMC Medical Research Methodology at the 35th Annual Conference of the ..  — BMC Pediatrics
The conference will focus on issues such as design and analysis of clinical trials, methods in biostatistics and development of clinical prediction models.

Pfizer Consumer Healthcare Pro Rogaine Extra Strength, 1 pack
Beauty (Pfizer Consumer Healthcare Pro)
  • 1 month supply.
  • To regrow hair on top of the scalp (vertex only, see pictures on side of carton, shown below). Not intended for frontal baldness or a receding hairline. It takes...
  • The amount of hair regrowth is different for each person. Rogaine Extra Strength for Men will not work for all men. Clinical research in mostly white men aged 18-49...
  • If your amount of hair loss is more than that shown on the side of this carton (shown below), or your hair loss is on the front of the scalp, Rogaine Extra Strength...
  • Continued use is necessary or hair loss will begin again. If you do not see hair regrowth in 4 months, stop use. In studies with Rogaine Extra Strength for Men...

Popular Q&A

avatar
What were the clinical results of the tuskegee study?

The results of the Tuskegee study are actually quite broad and too in depth to put into the text message character limit.

Related Posts